Medience메디앙스
014100 · KOSDAQ · ₩014100 · 메디앙스
₩1,598▼ ₩21 (1.30%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩49B | ₩49B | ₩66B | ₩71B | ₩72B |
| Cost of sales | ₩25B | ₩27B | ₩34B | ₩36B | ₩35B |
| Gross profit | ₩24B | ₩22B | ₩32B | ₩35B | ₩36B |
| Operating income | −₩1.1B | −₩8.8B | −₩1.3B | ₩1.6B | ₩4.5B |
| Net income | −₩6B | −₩14B | ₩7B | −₩12B | ₩4.4B |
| Net income to shareholders | −₩6B | −₩14B | ₩7B | −₩12B | ₩4.4B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩109B | ₩113B | ₩122B | ₩116B | ₩141B |
| Current assets | ₩23B | ₩24B | ₩27B | ₩31B | ₩40B |
| Cash and equivalents | ₩3.3B | ₩4.8B | ₩6.1B | ₩7.8B | ₩13B |
| Total liabilities | ₩41B | ₩39B | ₩35B | ₩35B | ₩48B |
| Current liabilities | ₩31B | ₩30B | ₩22B | ₩25B | ₩29B |
| Borrowings | ₩16B | ₩16B | ₩15B | ₩16B | ₩22B |
| Total equity | ₩68B | ₩74B | ₩87B | ₩81B | ₩93B |
| Shareholders' equity | ₩68B | ₩74B | ₩87B | ₩81B | ₩93B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩101,606 | −₩2.2B | ₩369M | ₩2.2B | ₩8.5B |
| Capital spending | ₩558M | ₩346M | ₩43M | ₩797M | ₩369M |
| Free cash flow | −₩558M | −₩2.5B | ₩326M | ₩1.4B | ₩8.2B |
Consolidated where available. Amounts in won.
Also known as: Medience / 메디앙스 / 014100 / KRX:014100
Source: KRX statistical information